# CDT Equity Inc. (CDT) Source: https://www.quantisnow.com/company/CDT Generated: 2026-11-08T18:04:43.028Z - Ticker: CDT - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: Pharmaceutical Preparations - IPO year: 2022 - SEC CIK: 0001896212 ## Latest CDT news and filings - 2026-11-06 14:15 UTC [SEC Schedule 13D] [Amendment: SEC Form SCHEDULE 13D/A filed by CDT Equity Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-cdt-equity-inc-6778269) - 2026-11-04 14:05 UTC [SEC Form 424B3] [SEC Form 424B3 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-cdt-equity-inc-6771716) - 2026-11-04 14:00 UTC [SEC Form 8-K] [CDT Equity Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cdt-equity-inc-filed-sec-form-8-k-material-modification-to-6771697) - 2026-11-03 21:15 UTC [SEC Form 424B3] [SEC Form 424B3 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-cdt-equity-inc-6769864) - 2026-10-30 12:32 UTC [CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides](https://www.quantisnow.com/insight/cdt-equity-welcomes-us-regulatory-development-supporting-expanded-access-to-6764693) - 2026-10-27 20:58 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-cdt-equity-inc-6759645) - 2026-10-27 20:33 UTC [SEC Form 4] [SEC Form 4 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-cdt-equity-inc-6759544) - 2026-10-27 20:30 UTC [SEC Form 4] [Amendment: SEC Form 4/A filed by CDT Equity Inc.](https://www.quantisnow.com/insight/amendment-sec-form-4a-filed-by-cdt-equity-inc-6759515) - 2026-10-27 20:24 UTC [SEC Form 3] [SEC Form 3 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-cdt-equity-inc-6759430) - 2026-10-27 12:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-cdt-equity-inc-6758661) - 2026-10-27 12:00 UTC [CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch](https://www.quantisnow.com/insight/cdt-partners-with-manoira-to-explore-enhancing-animal-health-products-6758559) - 2026-10-16 20:52 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-cdt-equity-inc-6749392) - 2026-10-14 12:10 UTC [CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset](https://www.quantisnow.com/insight/cdt-highlights-sarborgs-solid-form-patent-filing-on-a-first-in-class-respiratory-6745982) - 2026-10-13 12:05 UTC [SEC Form 424B3] [SEC Form 424B3 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-cdt-equity-inc-6744286) - 2026-10-13 12:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-cdt-equity-inc-6744258) - 2026-10-02 12:35 UTC [SEC Form 424B3] [SEC Form 424B3 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-cdt-equity-inc-6733566) - 2026-09-29 11:00 UTC [CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery](https://www.quantisnow.com/insight/cdt-highlights-sarborgs-expanding-quantum-computing-ip-portfolio-and-application-6728323) - 2026-09-25 12:15 UTC [SEC Form 8-K] [CDT Equity Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cdt-equity-inc-filed-sec-form-8-k-material-modification-to-6726059) - 2026-09-25 12:10 UTC [CDT Equity Inc. Announces Reverse Stock Split](https://www.quantisnow.com/insight/cdt-equity-inc-announces-reverse-stock-split-6726053) - 2026-09-18 21:20 UTC [SEC Form 424B3] [SEC Form 424B3 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-cdt-equity-inc-6720851) - 2026-09-18 21:15 UTC [SEC Form 8-K] [CDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cdt-equity-inc-filed-sec-form-8-k-entry-into-a-6720838) - 2026-09-18 20:30 UTC [SEC Form 424B3] [SEC Form 424B3 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-cdt-equity-inc-6720657) - 2026-09-18 10:30 UTC [CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo](https://www.quantisnow.com/insight/cdt-partners-with-qima-life-sciences-to-evaluate-novel-tapinarof-6719976) - 2026-09-18 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-cdt-equity-inc-6719946) - 2026-09-10 11:00 UTC [CDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental Health](https://www.quantisnow.com/insight/cdt-highlights-sarborgs-application-of-signature-intelligence-and-quantum-computing-6710764) - 2026-09-08 21:30 UTC [SEC Form S-1] [SEC Form S-1 filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-cdt-equity-inc-6708772) - 2026-09-04 20:05 UTC [SEC Form 8-K] [CDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cdt-equity-inc-filed-sec-form-8-k-entry-into-a-6706739) - 2026-09-02 22:12 UTC [SEC Form 4] [Chief Executive Officer Regan Andrew acquired 5,436,830 shares and sold 290 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-regan-andrew-acquired-5436830-shares-and-sold-6703829) - 2026-09-02 09:00 UTC [CDT Provides Capital Update and Confirms No Nasdaq Deficiencies](https://www.quantisnow.com/insight/cdt-provides-capital-update-and-confirms-no-nasdaq-deficiencies-6702082) - 2026-09-01 20:15 UTC [SEC Form 8-K] [CDT Equity Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/cdt-equity-inc-filed-sec-form-8-k-other-events-6701462) - 2026-09-01 12:00 UTC [SEC Form 8-K] [CDT Equity Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cdt-equity-inc-filed-sec-form-8-k-leadership-update-submission-6700626) - 2026-09-01 12:00 UTC [Leadership Update] [CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth](https://www.quantisnow.com/insight/cdt-appoints-co-founder-james-bligh-as-chief-executive-officer-to-6700560) - 2026-08-28 09:00 UTC [CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio](https://www.quantisnow.com/insight/cdt-validates-enhanced-solid-form-properties-within-its-ip-portfolio-6697776) - 2026-08-25 09:00 UTC [Conference Announcement] [CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market](https://www.quantisnow.com/insight/cdt-announces-investment-in-pepd-expanding-into-the-fast-growing-us-6693388) - 2026-08-21 13:27 UTC [SEC Form 8-K] [Amendment: CDT Equity Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-cdt-equity-inc-filed-sec-form-8-k-financial-statements-6690941) - 2026-08-21 13:27 UTC [SEC Form 8-K] [Amendment: CDT Equity Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/amendment-cdt-equity-inc-filed-sec-form-8-k-completion-of-6690940) - 2026-08-12 21:29 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cdt-equity-inc-6678644) - 2026-08-12 20:15 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-cdt-equity-inc-6678007) - 2026-08-11 12:45 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by CDT Equity Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-cdt-equity-inc-6675161) - 2026-08-06 20:30 UTC [SEC Form 8-K] [CDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/cdt-equity-inc-filed-sec-form-8-k-entry-into-a-6669557) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CDT - Earnings history: https://www.quantisnow.com/earnings/CDT - Dividend history: https://www.quantisnow.com/dividends/CDT - Insider transactions: https://www.quantisnow.com/insiders/CDT - Options chain: https://www.quantisnow.com/options/CDT - SEC 8-K filings only: https://www.quantisnow.com/company/CDT/8-k - RSS and alerts for CDT: https://www.quantisnow.com/docs/rss-feeds.md